Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 201 results.

Selected filters: Media

Displaying 91 to 100 of 201 records
Sort by: Page: << Prev 7… 8… 9… 10… 11… 12… 13… Next >>

New Compact and Low-Cost Lensless Radiomicroscope Developed for Nuclear Medicine Imaging – Mar 21, 2023
A novel, palm-sized imaging modality that can visualize the distribution of medical radiopharmaceuticals with very fine resolution has been developed and successfully tested, according to research published in March JNM. Known as the lensless radiomicroscope, the instrument offers the same level of imaging performance as its closest imaging equivalent but comes with significantly larger field of view and costs less than $100.
Novel PET Radiotracer Successfully Detects Multiple Cancers, Offers Potential for New Targeted Radionuclide Therapy – Mar 16, 2023
A new radiotracer, Ga-68 FAP-2286, has been found to be more effective than the most commonly used nuclear medicine cancer imaging radiotracer, F-18 FDG, according to a study published in JNM. Ga-68 FAP-2286 detected 100 percent of primary tumors across multiple cancer types as compared to F-18 FDG, which identified only 80 percent. Ga-68 FAP-2286 was also more effective in detecting lymph node metastases and distant metastases.
SNMMI Applauds Introduction of FIND Act of 2023: Legislation Will Ensure Patient Access to Innovative and Effective Diagnostic Imaging – Mar 6, 2023
SNMMI, along with more than 80 stakeholder organizations, supports and applauds the introduction of H.R. 1199, the Facilitating Innovative Nuclear Diagnostic (FIND) Act of 2023. The legislation will ensure patient access to innovative and effective diagnostic imaging.
SNMMI Mars Shot/Lobular Breast Cancer Alliance Announce Recipient of the Invasive Lobular Carcinoma Imaging Research Fellowship – Mar 1, 2023
The SNMMI Mars Shot Research Fund and the Lobular Breast Cancer Alliance (LBCA) are excited to announce that Marina Sharifi, MD, PhD, has been selected as the recipient of the joint SNMMI/LBCA Invasive Lobular Carcinoma Imaging Research Fellowship.
JNM Publishes Procedure Standard/Practice Guideline for SSTR PET Imaging of Neuroendocrine Tumors – Feb 21, 2023
SNMMI and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline to assist physicians in recommending, performing, interpreting, and reporting the results of somatostatin receptor (SSTR) PET imaging for patients with neuroendocrine tumors. The guideline is published in the February issue of The Journal of Nuclear Medicine.
New Dual-Phase Imaging Protocol Reduces Costs and Radiation Exposure for Cognitively Impaired Patients – Feb 8, 2023
A new nuclear medicine imaging protocol can assess both amyloid and neurodegeneration with a single tracer injection, cutting costs and radiation exposure for patients as well as providing them greater comfort. This research was published in the February issue of The Journal of Nuclear Medicine.
E-Cigarettes Potentially Harmful: PET Imaging Shows Greater Lung Inflammation in E-Cigarette Users Than Cigarette Smokers – Jan 25, 2023
PET imaging shows greater lung inflammation in e-cigarette users than in cigarette smokers, according to a new study published ahead of print in JNM.
Nearly Half of Medicare Patients with Non-Small Cell Lung Cancer Not Staged According to National Guidelines: Lack of Adherence Linked to Greater Mortality Rates – Jan 17, 2023
A study published in the January JNM reports that approximately half of Medicare patients with NSCLC do not receive the appropriate imaging prior to radiation therapy. Significant improvement in survival rates was found in patients who had FDG PET/CT imagingas recommended in NCCN guidelinescompared to those who underwent CT imaging alone.
Novel PET Radiotracer Reduces Number of False-Positive Cancer Findings After COVID-19 Vaccination – Jan 10, 2023
A novel imaging agent, Ga-68 FAPI, can reduce the number of false-positive PET/CT findings among cancer patients recently vaccinated for COVID-19, helping prevent costly follow-up and false management decisions for cancer patients.
PSMA PET/MRI Accurately Predicts Risk of Prostate Cancer Recurrence – Jan 5, 2023
In men recently diagnosed with intermediate or high-grade prostate cancer, PSMA PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy.

Displaying 91 to 100 of 201 records
Page: << Prev 7… 8… 9… 10… 11… 12… 13… Next >>